Regulatory Instrument Details
51-105 Issuers Quoted In the U.S. Over-The-Counter Markets [MI]
51-105
Number
Title
Regulatory Instrument Type
Date Type
Date
51-105
Issuers Quoted in the U.S. Over-the-Counter Markets - Consolidated Version
As Amended - Multilateral Instrument - 06/09/2023
Multilateral Instrument
As Amended
06/09/2023
51-105F1
Notice - OTC Issuer Ceases to be an OTC Reporting Issuer
Effective - Form - 07/31/2012
Form
Effective
07/31/2012
51-105F3A
Personal Information Form and Authorization of Indirect Collection, Use and Disclosure of Personal Information - Consolidation Version
As Amended - Form - 06/09/2023
Form
As Amended
06/09/2023
51-105F3B
Personal Information Form and Authorization of Indirect Collection, Use and Disclosure of Personal Information
Effective - Form - 07/31/2012
Form
Effective
07/31/2012
51-105F4
Notice - Issuer Ceases to be an OTC Reporting Issuer
Effective - Form - 07/31/2012
Form
Effective
07/31/2012
51-105CP
Companion Policy to MI 51-105 - Consolidated Version
As Changed - Companion Policy - 06/09/2023
Companion Policy
As Changed
06/09/2023
Proposed Amendments Related to 51-105
Number
Title
Regulatory Instrument Type
Date Type
Date
Proposed Amendments and Changes to Certain National Instruments and Policies related to the Senior Tier of the Canadian Securities Exchange, the Cboe Canada Inc. and AQSE Growth Market name changes, and Majority Voting Form of Proxy Requirements
Published - CSA Notice - 08/01/2024
CSA Notice
Published
08/01/2024
51-105
Proposed Amendments to MI 51-105 (arising from NI 51-102)
Published - Proposed Amendments to Instrument - 05/20/2021
Proposed Amendments to Instrument
Published
05/20/2021
Number
Title
Regulatory Instrument Type
Status
Date
Request for Comment Proposed Amendments to NI 51-102 and Other Amendments and Changes Relating to Annual and Interim Filings of Non-Investment Fund Reporting Issuers and Seeking Feedback on a Proposed Framework (includes comment letters received)
Published - CSA Notice - 05/20/2021
CSA Notice
Published
05/20/2021
45-514
Certain Private Placements - Varied
As Amended - Blanket Order - 11/07/2017
Blanket Order
As Amended
11/07/2017
Number
Title
Regulatory Instrument Type
Status
Date
51-105CP
Changes to 51-105CP (arising from NI 13-103)
Effective - Changes to Policy - 06/09/2023
Changes to Policy
Effective
06/09/2023
51-105
Amendments to MI 51-105 (arising from NI 13-103)
Effective - Amendments to Instrument - 06/09/2023
Amendments to Instrument
Effective
06/09/2023
51-105CP
Changes to 51-105CP (arising from NI 52-112)
Effective - Changes to Policy - 08/25/2021
Changes to Policy
Effective
08/25/2021
51-105
Amendments to MI 51-105 (arising from MI 62-104)
Effective - Amendments to Instrument - 05/09/2016
Amendments to Instrument
Effective
05/09/2016
51-105
Amendments to MI 51-105 (arising from the recognition of Aequitas NEO Exchange Inc. as an Exchange)
Effective - Amendments to Instrument - 11/17/2015
Amendments to Instrument
Effective
11/17/2015
51-105CP
Changes to 51-105CP (arising from amendments to NI 45-106 relating to the Accredited Investor and Minimum Amount Investment Prospectus Exemptions)
Effective - Changes to Policy - 05/05/2015
Changes to Policy
Effective
05/05/2015
51-105
Issuers Quoted in the U.S. Over-the-Counter Markets
Effective - Multilateral Instrument - 07/31/2012
Multilateral Instrument
Effective
07/31/2012
51-105F3A
Personal Information Form and Authorization of Indirect Collection, Use and Disclosure of Personal Information
Effective - Form - 07/31/2012
Form
Effective
07/31/2012
51-105CP
Companion Policy to MI 51-105
Effective - Companion Policy - 07/31/2012
Companion Policy
Effective
07/31/2012
51-105
Notice of Implementation of MI 51-105
Published - CSA Notice - 05/10/2012
CSA Notice
Published
05/10/2012
51-105
Request for Comment Proposed MI 51-105
Published - CSA Notice - 06/10/2011
CSA Notice
Published
06/10/2011
News Releases Related to 51-105
Title
Date
Atacama International Inc. and Glenn Brian Grant settle with the ASC for breaching Cease Trade Order
Dec 02, 2024
Nov 28, 2024
Feb 27, 2023